An inducible model of hepatic acid ceramidase (ASAH) overexpression and ceramide deacylation has been developed previously and used to demonstrate improved insulin sensitivity and hepatic steatosis in high-fat diet-fed mice (20). The gene discussed is ASAH1; the disease is fatty liver disease.